Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DOCCENTRA ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.0% 12.4% 47.2% 20.4% 21.5% 17.0% 20.6% 20.4%   Credit score (0-100)   21 20 0 4 4 9 5 5   Credit rating   BB BB C B B BB B B   Credit limit (kDKK)   0.0 0.0 -0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,347 112 1,026 1,221 1,582 1,471 0.0 0.0   EBITDA   4.1 -136 -669 464 283 -182 0.0 0.0   EBIT   4.1 -136 -669 464 283 -182 0.0 0.0   Pre-tax profit (PTP)   4.3 -156.4 -675.5 412.8 259.8 -163.6 0.0 0.0   Net earnings   -0.4 -129.3 -528.6 310.7 199.5 -129.2 0.0 0.0   Pre-tax profit without non-rec. items   4.3 -156 -676 413 260 -164 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   224 95.1 -433 -123 76.9 -52.3 -132 -132   Interest-bearing liabilities   16.4 31.3 31.7 102 0.0 2.6 132 132   Balance sheet total (assets)   463 184 503 315 421 609 0.0 0.0   Net Debt   -351 5.6 -79.9 87.6 -60.9 -29.4 132 132     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,347 112 1,026 1,221 1,582 1,471 0.0 0.0   Gross profit growth   -8.4% -91.7% 815.2% 18.9% 29.6% -7.0% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   463 184 503 315 421 609 0 0   Balance sheet change%   -64.9% -60.2% 173.1% -37.4% 33.9% 44.5% -100.0% 0.0%   Added value   4.1 -136.3 -669.2 464.0 282.8 -182.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 -2.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.3% -121.5% -65.2% 38.0% 17.9% -12.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.8% -41.6% -119.2% 67.7% 74.3% -26.5% 0.0% 0.0%   ROI %   3.0% -73.3% -844.5% 693.8% 355.9% -360.5% 0.0% 0.0%   ROE %   -0.2% -80.9% -176.8% 76.0% 101.9% -37.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   48.5% 51.7% -46.3% -28.0% 18.2% -7.9% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -8,459.7% -4.1% 11.9% 18.9% -21.5% 16.2% 0.0% 0.0%   Gearing %   7.3% 32.8% -7.3% -83.4% 0.0% -5.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   32.7% 91.4% 25.5% 77.6% 115.4% 1,555.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.9 2.1 0.4 0.7 1.2 0.9 0.0 0.0   Current Ratio   1.9 2.1 0.4 0.7 1.2 0.9 0.0 0.0   Cash and cash equivalent   367.4 25.6 111.6 14.7 60.9 32.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   224.5 95.1 -607.5 -122.7 76.9 -52.3 -66.2 -66.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   4 -136 -669 464 283 -182 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   4 -136 -669 464 283 -182 0 0   EBIT / employee   4 -136 -669 464 283 -182 0 0   Net earnings / employee   -0 -129 -529 311 200 -129 0 0